Leukemia gene mutations linked to survival odds
New York: Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research.
Two studies, published in the latest edition of the New England Journal of Medicine, show that genetic testing can guide doctors in how best to use current therapies as well as identify new drug targets.
"As lots of studies identify new alterations in genes in leukemia and other cancers, we need to begin to understand how these alterations in DNA can predict outcomes and determine differences in treatment," said Dr. Ross Levine of Memorial Sloan-Kettering Cancer Center in New York, the lead author of one of the studies.
Such personalized therapy is considered the new frontier for medical practice, and hopes for its success underpin a $5.7 billion hostile bid by drugmaker Roche Holding for gene sequencing company Illumina.
The second study, from Washington University in St. Louis, found that 85 percent of bone marrow cells in patients with myelodysplastic syndrome, a blood-related disorder that can precede AML, were linked to mutations in progressive cancer.
The Sloan-Kettering study analyzed bone marrow samples from 502 AML patients for mutations in 18 genes associated with the disease. The researchers were able to categorize two-thirds of the patients into groups clearly defined by their survival chances.
The study found that high-dose chemotherapy improved the rate of survival for patients with three specific genetic mutations, compared with standard-dose chemo.
It also showed that genetic profiling makes it possible to more precisely determine which patients are most likely to have their leukemia return after treatment.
AML is typically cured in about 40 percent of adults between the ages of 18 and 60, according to Levine.
"We were able to identify a very large subset of patients who need new therapies," he said. "Another set was found to do incredibly well with existing therapies, and that is very informative."
The American Cancer Society estimates that AML will be diagnosed in nearly 14,000 Americans this year and that more than 10,000 people will die from the disease.
Gene profiling for AML, and most other cancers, is not currently part of standard clinical practice.
"There are aspects of this that are ready to be adopted," Levine said, adding that the immediate hurdles are the cost of genetic testing and intellectual property rights pertaining to genes that have been patented.
And questions remain about the number of genetic mutations that AML patients should be screened for.
"It is exciting to think that the goal of personalized medicine is quickly approaching," Dr. Lucy Godley said in a NEJM editorial. "But it will require careful thought to implement genomic-based clinical evaluation in a way that is meaningful for patients."
More from India
More from World
More from Sports
More from Entertaiment
- Vadodara: Policemen seen dancing with bar girls
- PM Modi speaks at Golden Jubilee celebrations of poet Dinkar’s works
- Zee Media Exclusive: Kangana, Madhavan talk about their film 'Tanu Weds Manu Returns'
- DNA: Harmful chemicals found in Maggi, Nestle India still in denial mode
- One year of Modi govt: Arun Jaitley addresses press conference
- CM Kejriwal shortlists 39 'unwanted' IAS officers in Delhi
- Zee Media Exclusive interview with Congress leader Kamal Nath
- DNA: Modi-led NDA govt's hits and misses in one year
- Rajasthan: Gujjars revive reservation agitation, block rail track
- J Jayalalithaa sworn-in as Chief Minister of Tamil Nadu
- Mumbai: One injured in shootout at Film City
- Delhi: Car catches fire after crash, one dead
- ISIS to buy first nuclear weapon from Pak?
- Mumbai: CCTV captures assailant with gun at Film City
- Dr Subhash Chandra Show: Aspiring for more than what you have!
- IPL 2015, Qualifier 2: CSK vs RCB - As it happened...
- Tanu Weds Manu Returns movie review: Kangana Ranaut steals the show!
- India to soon have its own space shuttle!
- Kejriwal slams notification on LG's powers, says Modi running Delhi govt through back door
- PM Narendra Modi graces Digvijay Singh's son wedding reception
- Rahul Gandhi to pressurise govt to act on one-rank-one-pension issue
- Goa Board SSC Exam Results 2015 announced
- CBSE 12th Results 2015: CBSE Board Cbse.nic.in & cbseresults.nic class 12th XII board exam Results 2015 date announced
- ISIS close to buying nuclear weapon from Pakistan?
- Businessman shot next to Amitabh Bachchan's shooting location in Mumbai Film City
- Manohar Parrikar visits forward areas along LoC, reviews security situation
- RBSE 12th Science & Commerce Board Result 2015 declared
- RBSE rajresults.nic.in & rajeduboard.nic.in 12th Results 2015: BSER Ajmer Rajasthan Board Class 12th XII Senior Secondary Science & Commerce Exam Results 2015 to be declared shortly
- There will be no delay in appointing CIC, CVC: Jitendra Singh
- rajresults.nic.in RBSE Rajasthan Board BSER Class 12th Science and Commerce Exam Results 2015 to be declared shortly